← Leaderboards
Ankit Bharat
Northwestern University
$12,537,683
Attributed
$18,323,327
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.1M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,931,354 · 9
By mechanism
R01$16,332,150 · 5
P01$6,820,342 · 3
K08$778,862 · 1
Top collaborators
- Gr Scott Budinger14 shared
- Vadim Backman2 shared
- Hariharan Subramanian2 shared
Most similar at Northwestern University
Same institution · by research overlap
- Vadim Backman$34,873,053
- Gr Scott Budinger$22,037,096
- Jacob I Sznajder$35,275,438
- Hariharan Subramanian$1,672,189
- Navdeep S. Chandel$27,298,013
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungMediatingTransplantationMortalityLung TransplantationRecruitMouse ModelNeutrophil InfiltrationLung InjuryMonocyteNeutrophilFunctional DisorderSignal TransductionMolecularEndotheliumCellsInjuryAffectReperfusion InjuryPathway InteractionsSignal PathwayChronicAllograftingPublishing
Grant awards (36)
Integrated mechanisms of primary and chronic graft dysfunction following lung transplantation$2,804,066
P01 · FY2025 · HL · contact PI
Complementary pathways of necroptosis in recipient and donor lung tissue that drive primary lung allograft dysfunction$784,954
R01 · FY2025 · HL · contact PI
Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery$773,403
R01 · FY2025 · HL · contact PI
Donor nonclassical monocytes mediate primary graft dysfunction and remote organ injury following lung transplant surgery$693,741
R01 · FY2025 · HL · contact PI
Pathogenesis of lung injury mediated by lung-restricted antibodies$679,467
R01 · FY2025 · HL · contact PI
Translating buccal nanocytology for lung cancer screening into clinical practice$667,591
R01 · FY2025 · CA
Synergistic roles of lung autoantibodies, donor nonclassical monocytes and recipient classical monocytes in mediating primary graft dysfunction$457,196
P01 · FY2025 · HL · contact PI
Core A: Administrative Core$145,454
P01 · FY2025 · HL · contact PI
Integrated mechanisms of primary and chronic graft dysfunction following lung transplantation$2,803,961
P01 · FY2024 · HL · contact PI
Complementary pathways of necroptosis in recipient and donor lung tissue that drive primary lung allograft dysfunction$799,354
R01 · FY2024 · HL · contact PI
Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery$772,046
R01 · FY2024 · HL · contact PI
Donor nonclassical monocytes mediate primary graft dysfunction and remote organ injury following lung transplant surgery$717,581
R01 · FY2024 · HL · contact PI
Translating buccal nanocytology for lung cancer screening into clinical practice$682,587
R01 · FY2024 · CA
Pathogenesis of lung injury mediated by lung-restricted antibodies$674,627
R01 · FY2024 · HL · contact PI
Synergistic roles of lung autoantibodies, donor nonclassical monocytes and recipient classical monocytes in mediating primary graft dysfunction$464,211
P01 · FY2024 · HL · contact PI
Core A: Administrative Core$145,454
P01 · FY2024 · HL · contact PI
Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery$797,403
R01 · FY2023 · HL · contact PI
Pathogenesis of lung injury mediated by lung-restricted antibodies$711,603
R01 · FY2023 · HL · contact PI
Donor nonclassical monocytes initiate lung injury following transplantation$551,227
R01 · FY2023 · HL · contact PI
Pathogenesis of lung injury mediated by lung-restricted antibodies$613,633
R01 · FY2022 · HL · contact PI
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant$591,457
R01 · FY2022 · HL · contact PI
Donor nonclassical monocytes initiate lung injury following transplantation$551,227
R01 · FY2022 · HL · contact PI
Pathogenesis of lung injury mediated by lung-restricted antibodies$614,360
R01 · FY2021 · HL · contact PI
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant$591,457
R01 · FY2021 · HL · contact PI
Donor nonclassical monocytes initiate lung injury following transplantation$551,227
R01 · FY2021 · HL · contact PI
Pathogenesis of lung injury mediated by lung-restricted antibodies$614,360
R01 · FY2020 · HL · contact PI
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant$591,457
R01 · FY2020 · HL · contact PI
Donor nonclassical monocytes initiate lung injury following transplantation$551,227
R01 · FY2020 · HL · contact PI
Pathogenesis of lung injury mediated by lung-restricted antibodies$612,434
R01 · FY2019 · HL · contact PI
Role of Spleen educated monocytes in mediating ischemia-reperfusion injury following lung transplant$592,500
R01 · FY2019 · HL · contact PI
Donor nonclassical monocytes initiate lung injury following transplantation$551,227
R01 · FY2019 · HL · contact PI
High carbon dioxide impairs lung repair$162,086
K08 · FY2019 · HL · contact PI
High carbon dioxide impairs lung repair$162,086
K08 · FY2018 · HL · contact PI
High carbon dioxide impairs lung repair$162,086
K08 · FY2017 · HL · contact PI
High carbon dioxide impairs lung repair$162,086
K08 · FY2016 · HL · contact PI
High carbon dioxide impairs lung repair$130,518
K08 · FY2015 · HL · contact PI